Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET. - Wikidata - wikimedia - TriplyDB

Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.

Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.

http://www.wikidata.org/entity/Q48341481

about

Validation of the prognostic Heidelberg re-irradiation score in an independent mono-institutional patient cohort.Recurrence pattern analysis after re-irradiation with bevacizumab in recurrent malignant glioma patients Reirradiation in progressive high-grade gliomas: outcome, role of concurrent chemotherapy, prognostic factors and validation of a new prognostic score with an independent patient cohort.Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients.18F-FET PET prior to recurrent high-grade glioma re-irradiation-additional prognostic value of dynamic time-to-peak analysis and early static summation images?Performance of 18F-FET versus 18F-FDG-PET for the diagnosis and grading of brain tumors: systematic review and meta-analysis.Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?Amino acid PET and MR perfusion imaging in brain tumours.Carbon-11 and Fluorine-18 Labeled Amino Acid Tracers for Positron Emission Tomography Imaging of Tumors.Positron emission tomography imaging in gliomas: applications in clinical diagnosis, for assessment of prognosis and of treatment effects, and for detection of recurrences.O-(2-[(18)F]fluoroethyl)-L-tyrosine uptake is an independent prognostic determinant in patients with glioma referred for radiation therapy.Usefulness of PET Imaging to Guide Treatment Options in Gliomas.Impact of 18F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy.Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment option.

P2860

Q33851320-30941532-3A02-43B5-905A-1A03A7A4E812 Q35018538-5CD7F899-33C9-4C2F-97DC-D28499C8D42B Q37000961-5D77EA43-61C4-4D2F-88DD-2ABA70F44EDD Q37641220-FBC3A1B6-C024-461B-A35F-D16DC39A6F5F Q38403271-45FBAE75-2C40-4317-A344-BF6CBE696C35 Q38561073-E74E4A07-F24C-4A19-B359-56E53BC01F9C Q38635290-7533F801-90C8-4D52-B9B0-6C0EA1D4A28C Q38691946-1F67F80F-F002-4F3C-A04B-5E3894861411 Q47833074-23E1E68F-B68A-4FA8-8161-D880CC5BFA01 Q48158155-316D831E-AAA0-4426-8404-67865BCDB357 Q48849722-45D5C92F-22D2-471D-ACC1-AECBAF63A106 Q48947048-7E4189A7-2081-4A7D-BBFD-4BEA31BEE072 Q55031317-77ED68CC-71A9-42C7-BBD8-2B094B094C91 Q55461224-A03D01D9-880D-4B79-9586-16BD10E95097

P2860

Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.

http://www.wikidata.org/entity/Q48341481

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.

@en

Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.

@nl

type

label

Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.

@en

Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.

@nl

prefLabel

Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.

@en

Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.

@nl

P1433

Q48341481-2E9B63FA-FD1B-40DA-8A81-B1CAC6A8C4BA

P1476

Q48341481-2B04099B-73FD-4516-A6FE-C1F3E783A362

P2093

Q48341481-0009278F-5213-4A5D-A1CE-727ADD56C2DE

Q48341481-2A5CD623-D2C5-4D7B-AF1C-EBD3F8D66382

Q48341481-31661A5E-A10D-4856-ACFA-0E0125DBAE4F

Q48341481-60D848B1-4C88-43B2-A46B-6EBF972AB6AE

Q48341481-AE52AFCE-5350-41E5-858F-C0341C349508

Q48341481-B34F3BA1-3518-40ED-A77A-786CA3BA7DD1

Q48341481-BEAE411D-78A7-4571-8E2D-07729F50B9A8

Q48341481-CB17F29B-9ED4-45D5-AEF9-7E2B5527CC4E

Q48341481-EE4AE1EF-E6B2-4B34-9E64-17DF96E7BAC9

P2860

Q48341481-013AC974-11EB-4EFB-993F-70F287F5D978

Q48341481-0808A64C-F491-4E1C-8D54-9CBB4A507D05

Q48341481-09FDE52C-48B5-4539-BF77-B76D77F17AB5

Q48341481-0ADF8609-A79B-4176-8999-6ACBD4726084

Q48341481-138D0681-5A43-49A8-9990-D0A8E5F8FB81

Q48341481-2FDC8F84-CD9F-4D8D-857F-7D9609DE4367

Q48341481-316B60B9-2BFA-481E-A4E8-E1537554DA2D

Q48341481-3AE6DA8B-9C89-4B9E-9F4B-713530E34263

Q48341481-3DFE2425-00F6-4923-9EA4-92A6DBBB6B69

Q48341481-3ED9FE27-B01D-4D0D-81E1-4B46AEE320ED

P2888

Q48341481-F7DD40CA-1892-4DCB-BAFF-AA462E48B49E

P304

Q48341481-21CD318F-7466-4261-8AC5-7028F2B10A2D

P31

Q48341481-7C4D6AA1-DE6A-4858-A911-76024A9B5680

P356

Q48341481-D8BDC8B8-0E01-42F6-A6BB-C6E4B86405DC

P433

Q48341481-DC8DFB3A-EA74-43C3-9A09-60F63E1F26AB

P478

Q48341481-2166645E-3146-41B7-9217-CE4EADF41620

P50

Q48341481-BCCED362-CE3E-465C-A100-68CEA9215C98

P577

Q48341481-0D5DA8BE-17C0-47CA-810E-8B4F98841C1E

P698

Q48341481-B0EDEE51-7EFF-4363-BCDF-0A75148EA56A

P356

S11060-012-0980-7

P1433

Journal of Neuro-Oncology

P1476

Re-irradiation in recurrent malignant glioma: prognostic value of [18F]FET-PET.

@en

P2093

Claus Belka

http://www.w3.org/2001/XMLSchema#string

Julia Geisler

http://www.w3.org/2001/XMLSchema#string

Karen Büsing

http://www.w3.org/2001/XMLSchema#string

Maximilian Niyazi

http://www.w3.org/2001/XMLSchema#string

Nathalie Jansen

http://www.w3.org/2001/XMLSchema#string

Oliver Schnell

http://www.w3.org/2001/XMLSchema#string

Sabina Eigenbrod

http://www.w3.org/2001/XMLSchema#string

Silke Birgit Schwarz

http://www.w3.org/2001/XMLSchema#string

Ute Ganswindt

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Molecular imaging of gliomas with PET: opportunities and limitations.

Molecular imaging of cancer with positron emission tomography.

Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity.

Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme--a dosimetric comparison.

Therapeutic options for recurrent malignant glioma.

Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide.

FET-PET for malignant glioma treatment planning.

Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.

Irradiation and bevacizumab in high-grade glioma retreatment settings.

P2888

s11060-012-0980-7

P304

389-395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-012-0980-7

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Christian la Fougère

P577

2012-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23054562

http://www.w3.org/2001/XMLSchema#string